The Effects of LL-37 on Virulence Factors Related to the Quorum Sensing System of

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2022 Apr 18

PMID 35434009

Authors

Qian Xiao

Yanfen Luo

Wen Shi

Yang Lu

Rui Xiong

Xinggui Wu

Haihao Huang

Chanjing Zhao

Jianming Zeng

Cha Chen

Affiliations

Soon will be listed here.

Abstract

Background: Antimicrobial peptides (AMPs) have shown promise in the treatment of multi-resistant pathogens. It was therefore of interest to analyze the effects of the AMP LL-37 on the regulation of several virulence factors related to the quorum sensing (QS) system of .

Methods: The minimum inhibitory concentration (MIC) was evaluated by the micro broth dilution method. The expression of QS-related and QS-regulated virulence factor genes was also evaluated. Exotoxin A activity was measured with the nicotinamide adenine dinucleotide (NAD) (Coenzyme I) method; Elastase activity was detected with the elastin-Congo red (ECR) method; Pyocyanin detection was performed using the chloroform extraction method. The effects of LL-37 were assessed by measuring the expression changes of the virulence protein-encoding genes of the strains with quantitative polymerase chain reaction (PCR).

Results: The MIC of LL-37 against both reference strain (ATCC 15692 PAO1) and Δ was therefore determined to be 256 µg/mL. LL-37 at sub-minimum inhibitory concentrations (sub-MICs) had no significant effects on bacterial growth (P>0.05), but significantly downregulated the expression of all 3 virulence factors.

Conclusions: Interestingly, this effect appeared to be dose-related. These findings suggest that LL-37 could be a potential candidate for QS inhibition against bacterial infection and may have significant clinical potential in the treatment of biofilms.

Citing Articles

Unravelling the mechanisms causing murepavadin resistance in : lipopolysaccharide alterations and its consequences.

Hernandez-Garcia M, Barbero-Herranz R, Baston-Paz N, Diez-Aguilar M, Lopez-Collazo E, Marquez-Garrido F Front Cell Infect Microbiol. 2024; 14:1446626.

PMID: 39711784 PMC: 11659217. DOI: 10.3389/fcimb.2024.1446626.

Biofilm inhibition/eradication: exploring strategies and confronting challenges in combatting biofilm.

Srivastava A, Verma N, Kumar V, Apoorva P, Agarwal V Arch Microbiol. 2024; 206(5):212.

PMID: 38616221 DOI: 10.1007/s00203-024-03938-0.

Molecular Aspects of the Functioning of Pathogenic Bacteria Biofilm Based on (QS) Signal-Response System and Innovative Non-Antibiotic Strategies for Their Elimination.

Juszczuk-Kubiak E Int J Mol Sci. 2024; 25(5).

PMID: 38473900 PMC: 10931677. DOI: 10.3390/ijms25052655.

Effects of synthetic peptide RP557 and its origin, LL-37, on carbapenem-resistant .

Song Y, Kyung S, Kim S, Kim G, Lee S, Yoo H Microbiol Spectr. 2023; :e0043023.

PMID: 37555659 PMC: 10581083. DOI: 10.1128/spectrum.00430-23.

Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators.

Ribeiro C, Higgs M, Muhlebach M, Wolfgang M, Borgatti M, Lampronti I Int J Mol Sci. 2023; 24(5).

PMID: 36902441 PMC: 10003689. DOI: 10.3390/ijms24055010.

References

Das T, Kutty S, Tavallaie R, Ibugo A, Panchompoo J, Sehar S . Phenazine virulence factor binding to extracellular DNA is important for Pseudomonas aeruginosa biofilm formation. Sci Rep. 2015; 5:8398. PMC: 4323658. DOI: 10.1038/srep08398. View

Lee J, Zhang L . The hierarchy quorum sensing network in Pseudomonas aeruginosa. Protein Cell. 2014; 6(1):26-41. PMC: 4286720. DOI: 10.1007/s13238-014-0100-x. View

Pompilio A, Scocchi M, Pomponio S, Guida F, Di Primio A, Fiscarelli E . Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. Peptides. 2011; 32(9):1807-14. DOI: 10.1016/j.peptides.2011.08.002. View

Chen K, Gong W, Huang J, Yoshimura T, Wang J . The potentials of short fragments of human anti-microbial peptide LL-37 as a novel therapeutic modality for diseases. Front Biosci (Landmark Ed). 2021; 26(11):1362-1372. DOI: 10.52586/5029. View

Chen R, Deziel E, Groleau M, Schaefer A, Greenberg E . Social cheating in a quorum-sensing variant. Proc Natl Acad Sci U S A. 2019; 116(14):7021-7026. PMC: 6452681. DOI: 10.1073/pnas.1819801116. View

Deziel E, Lepine F, Milot S, He J, Mindrinos M, Tompkins R . Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication. Proc Natl Acad Sci U S A. 2004; 101(5):1339-44. PMC: 337054. DOI: 10.1073/pnas.0307694100. View

Kuang Z, Hao Y, Walling B, Jeffries J, Ohman D, Lau G . Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A. PLoS One. 2011; 6(11):e27091. PMC: 3206073. DOI: 10.1371/journal.pone.0027091. View

Mathee K, Narasimhan G, Valdes C, Qiu X, Matewish J, Koehrsen M . Dynamics of Pseudomonas aeruginosa genome evolution. Proc Natl Acad Sci U S A. 2008; 105(8):3100-5. PMC: 2268591. DOI: 10.1073/pnas.0711982105. View

Bowdish D, Davidson D, Scott M, Hancock R . Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother. 2005; 49(5):1727-32. PMC: 1087655. DOI: 10.1128/AAC.49.5.1727-1732.2005. View

10.

Dong L, Pang J, Wang X, Zhang Y, Li G, Hu X . Mechanism of pyocyanin abolishment caused by double knockout in PAO1. Virulence. 2019; 11(1):57-67. PMC: 6961724. DOI: 10.1080/21505594.2019.1708052. View

11.

Mishra B, Wang G . Individual and Combined Effects of Engineered Peptides and Antibiotics on Pseudomonas aeruginosa Biofilms. Pharmaceuticals (Basel). 2017; 10(3). PMC: 5620602. DOI: 10.3390/ph10030058. View

12.

Gellatly S, Hancock R . Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis. 2013; 67(3):159-73. DOI: 10.1111/2049-632X.12033. View

13.

Fila G, Kawiak A, Grinholc M . Blue light treatment of Pseudomonas aeruginosa: Strong bactericidal activity, synergism with antibiotics and inactivation of virulence factors. Virulence. 2016; 8(6):938-958. PMC: 5626244. DOI: 10.1080/21505594.2016.1250995. View

14.

Uhlmann J, Rohde M, Siemens N, Kreikemeyer B, Bergman P, Johansson L . LL-37 Triggers Formation of Streptococcus pyogenes Extracellular Vesicle-Like Structures with Immune Stimulatory Properties. J Innate Immun. 2015; 8(3):243-57. PMC: 6738779. DOI: 10.1159/000441896. View

15.

Mulcahy L, Isabella V, Lewis K . Pseudomonas aeruginosa biofilms in disease. Microb Ecol. 2013; 68(1):1-12. PMC: 3977026. DOI: 10.1007/s00248-013-0297-x. View

16.

Ahmed A, A Salih F . Low concentrations of local honey modulate Exotoxin A expression, and quorum sensing related virulence in drug-resistant recovered from infected burn wounds. Iran J Basic Med Sci. 2019; 22(5):568-575. PMC: 6556501. DOI: 10.22038/ijbms.2019.33077.7902. View

17.

Brown K, Poon G, Birkenhead D, Pena O, Falsafi R, Dahlgren C . Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses. J Immunol. 2011; 186(9):5497-505. DOI: 10.4049/jimmunol.1002508. View

18.

Ohman D, Cryz S, Iglewski B . Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase. J Bacteriol. 1980; 142(3):836-42. PMC: 294108. DOI: 10.1128/jb.142.3.836-842.1980. View

19.

Fuqua C, Parsek M, Greenberg E . Regulation of gene expression by cell-to-cell communication: acyl-homoserine lactone quorum sensing. Annu Rev Genet. 2001; 35:439-68. DOI: 10.1146/annurev.genet.35.102401.090913. View

20.

Schuster M, Greenberg E . A network of networks: quorum-sensing gene regulation in Pseudomonas aeruginosa. Int J Med Microbiol. 2006; 296(2-3):73-81. DOI: 10.1016/j.ijmm.2006.01.036. View